HomeCLDX • NASDAQ
add
Celldex Therapeutics, Inc.
Previous close
$41.06
Day range
$39.50 - $41.97
Year range
$22.11 - $53.18
Market cap
2.63B USD
Avg Volume
617.37K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Top news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 4.13M | 156.11% |
Operating expense | 8.83M | 33.84% |
Net income | -43.31M | -63.50% |
Net profit margin | -1.05K | 36.16% |
Earnings per share | -0.59 | -5.73% |
EBITDA | -34.37M | -26.30% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 423.60M | 38.91% |
Total assets | 465.63M | 32.00% |
Total liabilities | 36.46M | 37.41% |
Total equity | 429.17M | — |
Shares outstanding | 55.90M | — |
Price to book | 5.35 | — |
Return on assets | -23.55% | — |
Return on capital | -25.78% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -43.31M | -63.50% |
Cash from operations | -32.53M | -49.49% |
Cash from investing | -171.16M | -648.36% |
Cash from financing | 217.37M | 15,482.37% |
Net change in cash | 13.68M | 26.13% |
Free cash flow | -8.94M | 24.13% |
About
Founded
1983
Headquarters
Website
Employees
160